Literature DB >> 6772784

Duration of corticosteroid therapy in giant cell arteritis.

L Fernandez-Herlihy.   

Abstract

A follow-up study of 29 patients with giant cell arteritis (GCA) was undertaken to determine the duration of corticosteroid treatment. In 20 patients the diagnosis was confirmed by biopsy of a temporal artery (Group 1). In 9 patients GCA was evident clinically (Group 2). Treatment was continued until reductions in corticosteroid dosage no longer resulted in clinical evidence of GCA. The mean duration of corticosteroid treatment was 6 yr. The diagnosis of GCA should be confirmed by means of a temporal artery biopsy before treatment is begun because it may commit the patient to years of corticosteroid treatment.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6772784

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  10 in total

1.  Prolonged corticosteroid treatment in the management of temporal arteritis.

Authors:  G Friedman; B Friedman
Journal:  Klin Wochenschr       Date:  1988-12-01

Review 2.  Treatment of vasculitis.

Authors:  H G Taylor; A Samanta
Journal:  Br J Clin Pharmacol       Date:  1993-02       Impact factor: 4.335

3.  Nonarticular rheumatism.

Authors:  M H Atkinson
Journal:  Can Fam Physician       Date:  1981-02       Impact factor: 3.275

Review 4.  Giant cell arteritis. Epidemiology and treatment.

Authors:  E Nordborg; R Andersson; B A Bengtsson
Journal:  Drugs Aging       Date:  1994-02       Impact factor: 3.923

5.  Polymyalgia rheumatica and corticosteroids: how much for how long?

Authors:  A R Behn; T Perera; A B Myles
Journal:  Ann Rheum Dis       Date:  1983-08       Impact factor: 19.103

6.  Temporal arteritis: a form of systemic panarteritis.

Authors:  A Sendino; F J Barbado; I González-Anglada; E Antón; F López-Barea; J J Vázquez
Journal:  Ann Rheum Dis       Date:  1992-09       Impact factor: 19.103

7.  Risk factors for early visual deterioration in temporal arteritis.

Authors:  Tobias Loddenkemper; Pankaj Sharma; I Katzan; Gordon T Plant
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-05-15       Impact factor: 10.154

8.  Can methotrexate be used as a steroid sparing agent in the treatment of polymyalgia rheumatica and giant cell arteritis?

Authors:  M J van der Veen; H J Dinant; C van Booma-Frankfort; G A van Albada-Kuipers; J W Bijlsma
Journal:  Ann Rheum Dis       Date:  1996-04       Impact factor: 19.103

9.  Development of an evidence-based regimen of prednisolone to treat giant cell arteritis - the Norwich regimen.

Authors:  Chetan Mukhtyar; Heidi Cate; Conor Graham; Peter Merry; Karen Mills; Aseema Misra; Colin Jones
Journal:  Rheumatol Adv Pract       Date:  2019-02-01

10.  Fatal aortic dissection in a patient with giant cell arteritis: a case report and review of the literature.

Authors:  Anjeli K Nayar; Michael Casciello; Jennifer N Slim; Ahmad M Slim
Journal:  Case Rep Vasc Med       Date:  2013-02-26
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.